Chapter 1. Market Scope & Methodology
1.1 Market Definition
1.2 Objectives
1.3 Market Scope
1.4 Segmentation
1.4.1 North America Microbial Fermentation Technology Market, by Application
1.4.2 North America Microbial Fermentation Technology Market, by End User
1.4.3 North America Microbial Fermentation Technology Market, by Country
1.5 Methodology for the research
Chapter 2. Market Overview
2.1 Introduction
2.1.1 Overview
2.1.1.1 Market Composition & Scenario
2.2 Key Factors Impacting the Market
2.2.1 Market Drivers
2.2.2 Market Restraints
Chapter 3. Strategies Deployed in Microbial Fermentation Technology Market
Chapter 4. North America Microbial Fermentation Technology Market by Application
4.1 North America Antibiotics Market by Country
4.2 North America Recombinant Proteins Market by Country
4.3 North America Enzymes Market by Country
4.4 North America Monoclonal Antibodies Market by Country
4.5 North America Probiotics Supplements Market by Country
4.6 North America Vaccines Market by Country
4.7 North America Biosimilars Market by Country
4.8 North America Small Molecules Market by Country
4.9 North America Others Market by Country
Chapter 5. North America Microbial Fermentation Technology Market by End-user
5.1 North America CMOs & CDMOs Market by Country
5.2 North America Bio-Pharmaceutical Companies Market by Country
5.3 North America Contract Research Organizations (CROs) Market by Country
5.4 North America Others Market by Country
Chapter 6. North America Microbial Fermentation Technology Market by Country
6.1 US Microbial Fermentation Technology Market
6.1.1 US Microbial Fermentation Technology Market by Application
6.1.2 US Microbial Fermentation Technology Market by End-user
6.2 Canada Microbial Fermentation Technology Market
6.2.1 Canada Microbial Fermentation Technology Market by Application
6.2.2 Canada Microbial Fermentation Technology Market by End-user
6.3 Mexico Microbial Fermentation Technology Market
6.3.1 Mexico Microbial Fermentation Technology Market by Application
6.3.2 Mexico Microbial Fermentation Technology Market by End-user
6.4 Rest of North America Microbial Fermentation Technology Market
6.4.1 Rest of North America Microbial Fermentation Technology Market by Application
6.4.2 Rest of North America Microbial Fermentation Technology Market by End-user
Chapter 7. Company Profiles
7.1 Biocon Limited
7.1.1 Company Overview
7.1.2 Financial Analysis
7.1.3 Segmental and Regional Analysis
7.1.4 Research & Development Expenses
7.1.5 Recent strategies and developments:
7.1.5.1 Acquisition and Mergers:
7.2 BioVectra Inc. (H.I.G. Capital, LLC)
7.2.1 Company Overview
7.2.2 Recent strategies and developments:
7.2.2.1 Partnerships, Collaborations, and Agreements:
7.2.2.2 Product Launches and Product Expansions:
7.2.2.3 Geographical Expansions:
7.3 Danone S.A.
7.3.1 Company Overview
7.3.2 Financial Analysis
7.3.3 Category and Regional Analysis
7.3.4 Recent strategies and developments:
7.3.4.1 Geographical Expansions:
7.4 F. Hoffmann-La Roche Ltd.
7.4.1 Company Overview
7.4.2 Financial Analysis
7.4.3 Segmental and Regional Analysis
7.4.4 Research & Development Expense
7.5 Koninklijke DSM N.V.
7.5.1 Company Overview
7.5.2 Financial Analysis
7.5.3 Segmental and Regional Analysis
7.5.4 Research & Development Expense
7.5.5 Recent strategies and developments:
7.5.5.1 Acquisition, Joint Venture and Mergers:
7.6 Lonza Group AG
7.6.1 Company Overview
7.6.2 Financial Analysis
7.6.3 Segmental and Regional Analysis
7.6.4 Research & Development Expenses
7.7 Novozymes A/S (Novo Holdings A/S)
7.7.1 Company Overview
7.7.2 Financial Analysis
7.7.3 Regional Analysis
7.7.4 Research & Development Expense
7.7.5 Recent strategies and developments:
7.7.5.1 Product Launches and Product Expansions:
7.8 Corbion N.V.
7.8.1 Company Overview
7.8.2 Financial Analysis
7.8.3 Segmental and Regional Analysis
7.8.4 Research & Development Expense
7.9 Bangalore Biotech Labs Pvt. Ltd. (BiOZEEN)
7.9.1 Company Overview
Unique Offerings 